1. Home
  2. IMAB vs TRX Comparison

IMAB vs TRX Comparison

Compare IMAB & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • TRX
  • Stock Information
  • Founded
  • IMAB 2014
  • TRX 1990
  • Country
  • IMAB United States
  • TRX Canada
  • Employees
  • IMAB N/A
  • TRX N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • TRX
  • Sector
  • IMAB Health Care
  • TRX
  • Exchange
  • IMAB Nasdaq
  • TRX Nasdaq
  • Market Cap
  • IMAB 200.9M
  • TRX 90.0M
  • IPO Year
  • IMAB 2020
  • TRX N/A
  • Fundamental
  • Price
  • IMAB $2.16
  • TRX $0.33
  • Analyst Decision
  • IMAB Strong Buy
  • TRX Strong Buy
  • Analyst Count
  • IMAB 2
  • TRX 1
  • Target Price
  • IMAB $6.00
  • TRX $1.50
  • AVG Volume (30 Days)
  • IMAB 982.8K
  • TRX 409.7K
  • Earning Date
  • IMAB 05-15-2025
  • TRX 07-22-2025
  • Dividend Yield
  • IMAB N/A
  • TRX N/A
  • EPS Growth
  • IMAB N/A
  • TRX N/A
  • EPS
  • IMAB N/A
  • TRX N/A
  • Revenue
  • IMAB N/A
  • TRX $45,405,000.00
  • Revenue This Year
  • IMAB N/A
  • TRX $51.45
  • Revenue Next Year
  • IMAB N/A
  • TRX $26.19
  • P/E Ratio
  • IMAB N/A
  • TRX N/A
  • Revenue Growth
  • IMAB N/A
  • TRX 26.50
  • 52 Week Low
  • IMAB $0.60
  • TRX $0.27
  • 52 Week High
  • IMAB $3.08
  • TRX $0.45
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 50.70
  • TRX 48.65
  • Support Level
  • IMAB $2.00
  • TRX $0.33
  • Resistance Level
  • IMAB $2.95
  • TRX $0.36
  • Average True Range (ATR)
  • IMAB 0.34
  • TRX 0.01
  • MACD
  • IMAB -0.08
  • TRX -0.00
  • Stochastic Oscillator
  • IMAB 15.79
  • TRX 25.00

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About TRX TRX Gold Corporation

TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.

Share on Social Networks: